B7-1 (CD80) as target for immunotoxin therapy for Hodgkin's disease. 1997. Br. J. Cancer. 76:1163. Human B7-1 is more efficient than B7-2 in providing costimulation for allo- antigen specific T-cells

A.M.C. van Dijk; H.G. Otten; S.M. Vercauteren; F.L. Kessler; L.F. Verdonck; M. de Boer; G.C. de Gast

B7-1 (CD80) as target for immunotoxin therapy for Hodgkin's disease. 1997. Br. J. Cancer. 76:1163. Human B7-1 is more efficient than B7-2 in providing costimulation for allo- antigen specific T-cells

A.M.C. van Dijk, H.G. Otten, S.M. Vercauteren, F.L. Kessler, L.F. Verdonck, M. de Boer, G.C. de Gast

Utrecht University

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	2275-2278
Number of pages	4
Journal	European Journal of Immunology
Volume	26
Publication status	Published - 1996

Cite this

van Dijk, A. M. C., Otten, H. G., Vercauteren, S. M., Kessler, F. L., Verdonck, L. F., de Boer, M., & de Gast, G. C. (1996). B7-1 (CD80) as target for immunotoxin therapy for Hodgkin's disease. 1997. Br. J. Cancer. 76:1163. Human B7-1 is more efficient than B7-2 in providing costimulation for allo- antigen specific T-cells. European Journal of Immunology, 26, 2275-2278.

@article{c90e73957bd44aad97a69a091c3f8477,

title = "B7-1 (CD80) as target for immunotoxin therapy for Hodgkin's disease. 1997. Br. J. Cancer. 76:1163. Human B7-1 is more efficient than B7-2 in providing costimulation for allo- antigen specific T-cells",

author = "{van Dijk}, A.M.C. and H.G. Otten and S.M. Vercauteren and F.L. Kessler and L.F. Verdonck and {de Boer}, M. and {de Gast}, G.C.",

note = "keypublication",

year = "1996",

language = "Undefined/Unknown",

volume = "26",

pages = "2275--2278",

journal = "European Journal of Immunology",

issn = "0014-2980",

publisher = "Wiley-VCH Verlag",

}

B7-1 (CD80) as target for immunotoxin therapy for Hodgkin's disease. 1997. Br. J. Cancer. 76:1163. Human B7-1 is more efficient than B7-2 in providing costimulation for allo- antigen specific T-cells. / van Dijk, A.M.C.; Otten, H.G.; Vercauteren, S.M. et al.
In: European Journal of Immunology, Vol. 26, 1996, p. 2275-2278.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - B7-1 (CD80) as target for immunotoxin therapy for Hodgkin's disease. 1997. Br. J. Cancer. 76:1163. Human B7-1 is more efficient than B7-2 in providing costimulation for allo- antigen specific T-cells

AU - van Dijk, A.M.C.

AU - Otten, H.G.

AU - Vercauteren, S.M.

AU - Kessler, F.L.

AU - Verdonck, L.F.

AU - de Boer, M.

AU - de Gast, G.C.

N1 - keypublication

PY - 1996

Y1 - 1996

M3 - Article

SN - 0014-2980

VL - 26

SP - 2275

EP - 2278

JO - European Journal of Immunology

JF - European Journal of Immunology

ER -